Medicinal Plants: Guests and Hosts in the Heterologous Expression of High-Value Products
- 14 September 2021
- journal article
- review article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 88 (13), 1175-1189
- https://doi.org/10.1055/a-1576-4148
Abstract
Medicinal plants play an important dual role in the context of the heterologous expression of high-value pharmaceutical products. On the one hand, the classical biochemical and modern omics approaches allowed for the discovery of various genes encoding biosynthetic pathways in medicinal plants. Recombinant DNA technology enabled introducing these genes and regulatory elements into host organisms and enhancing the heterologous production of the corresponding secondary metabolites. On the other hand, the transient expression of foreign DNA in plants facilitated the production of numerous proteins of pharmaceutical importance. This review summarizes several success stories of the engineering of plant metabolic pathways in heterologous hosts. Likewise, a few examples of recombinant protein expression in plants for therapeutic purposes are also highlighted. Therefore, the importance of medicinal plants has grown immensely as sources for valuable products of low and high molecular weight. The next step ahead for bioengineering is to achieve more success stories of industrial-scale production of secondary plant metabolites in microbial systems and to fully exploit plant cell factoriesʼ commercial potential for recombinant proteins. Received: 16 May 2021 Accepted after revision: 30 July 2021 Article published online: 14 September 2021 © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
Funding Information
- Bundesministerium für Bildung und Forschung (03VP06370)
This publication has 145 references indexed in Scilit:
- Expression of functionally active sialylated human erythropoietin in plantsBiotechnology Journal, 2013
- Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisininProceedings of the National Academy of Sciences of the United States of America, 2012
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectantProceedings of the National Academy of Sciences of the United States of America, 2011
- A bacterial platform for fermentative production of plant alkaloidsNature Communications, 2011
- Integrating carbon–halogen bond formation into medicinal plant metabolismNature, 2010
- Genome-wide association studies of 14 agronomic traits in rice landracesNature Genetics, 2010
- Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiaeNature Chemical Biology, 2008
- Microbial production of plant benzylisoquinoline alkaloidsProceedings of the National Academy of Sciences of the United States of America, 2008
- Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Production of antibodies in transgenic plantsNature, 1989